268 related articles for article (PubMed ID: 27905004)
1. Ocular Disposition of ∆
Punyamurthula NS; Adelli GR; Gul W; Repka MA; ElSohly MA; Majumdar S
AAPS PharmSciTech; 2017 Aug; 18(6):1936-1945. PubMed ID: 27905004
[TBL] [Abstract][Full Text] [Related]
2. Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations.
Hingorani T; Adelli GR; Punyamurthula N; Gul W; Elsohly MA; Repka MA; Majumdar S
Pharm Res; 2013 Aug; 30(8):2146-56. PubMed ID: 23737345
[TBL] [Abstract][Full Text] [Related]
3. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
Balguri SP; Adelli GR; Majumdar S
Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery.
Hao J; Wang X; Bi Y; Teng Y; Wang J; Li F; Li Q; Zhang J; Guo F; Liu J
Colloids Surf B Biointerfaces; 2014 Feb; 114():111-20. PubMed ID: 24176890
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.
Sharma AK; Sahoo PK; Majumdar DK; Sharma N; Sharma RK; Kumar A
Drug Deliv; 2016 Nov; 23(9):3364-3373. PubMed ID: 27128623
[TBL] [Abstract][Full Text] [Related]
6. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
[TBL] [Abstract][Full Text] [Related]
7. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
8. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
[TBL] [Abstract][Full Text] [Related]
9. Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.
Hippalgaonkar K; Gul W; ElSohly MA; Repka MA; Majumdar S
AAPS PharmSciTech; 2011 Jun; 12(2):723-31. PubMed ID: 21637944
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S
Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828
[TBL] [Abstract][Full Text] [Related]
11. Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery.
Adelli GR; Balguri SP; Bhagav P; Raman V; Majumdar S
Drug Deliv; 2017 Nov; 24(1):370-379. PubMed ID: 28165833
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of topical hesperetin matrix film for back-of-the-eye delivery.
Adelli GR; Hingorani T; Punyamurthula N; Balguri SP; Majumdar S
Eur J Pharm Biopharm; 2015 May; 92():74-82. PubMed ID: 25728824
[TBL] [Abstract][Full Text] [Related]
13. In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies.
Tatke A; Dudhipala N; Janga KY; Balguri SP; Avula B; Jablonski MM; Majumdar S
Nanomaterials (Basel); 2018 Dec; 9(1):. PubMed ID: 30591688
[TBL] [Abstract][Full Text] [Related]
14. A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.
Rathod LV; Kapadia R; Sawant KK
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():529-540. PubMed ID: 27987741
[TBL] [Abstract][Full Text] [Related]
15. Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies.
Wang J; Zhao F; Liu R; Chen J; Zhang Q; Lao R; Wang Z; Jin X; Liu C
Int J Nanomedicine; 2017; 12():8115-8127. PubMed ID: 29158673
[TBL] [Abstract][Full Text] [Related]
16. Gellan Gum Based
Janga KY; Tatke A; Dudhipala N; Balguri SP; Ibrahim MM; Maria DN; Jablonski MM; Majumdar S
J Pharmacol Exp Ther; 2019 Sep; 370(3):814-822. PubMed ID: 30872389
[TBL] [Abstract][Full Text] [Related]
17. Part II: Enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops.
Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K; Aljuffali IA; Alshamsan A
J Biomed Mater Res A; 2013 Jun; 101(6):1828-36. PubMed ID: 23184654
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
[TBL] [Abstract][Full Text] [Related]
19. Tailored nanostructured platforms for boosting transcorneal permeation: Box-Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization.
Elsayed I; Sayed S
Int J Nanomedicine; 2017; 12():7947-7962. PubMed ID: 29133980
[TBL] [Abstract][Full Text] [Related]
20. Formulation and In Vitro-Ex vivo Evaluation of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Applications.
Adel Ali Youssef A; Hayder Abdelrahman M; Geweda MM; Varner C; Joshi PH; Ghonge M; Dudhipala N; Sulochana SP; Gadepalli RS; Majumdar S
Int J Pharm; 2024 May; 657():124110. PubMed ID: 38604539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
